Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus
Open Access
- 2 July 2024
- journal article
- research article
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (8) , 1907-1913
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
This publication has 36 references indexed in Scilit:
- Glycemic Control, Weight Management, Cardiovascular Safety, and Cost-Effectiveness of Semaglutide for Patients with Type 2 Diabetes Mellitus: A Rapid Review and Meta-analysis of Real-World StudiesDiabetes Therapy, 2024
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or ObesityJAMA, 2021
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or ObesityJAMA, 2021
- The Effects of Very Low Energy Diets and Low Energy Diets with Exercise Training on Skeletal Muscle Mass: A Narrative ReviewAdvances in Therapy, 2020
- Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trialDiabetologia, 2017
- Effects of a very low-calorie diet on insulin sensitivity and insulin secretion in overweight/obese and lean type 2 diabetes patientsDiabetes & Metabolism, 2015
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerolDiabetologia, 2011
- The magnitude of association between overweight and obesity and the risk of diabetes: A meta-analysis of prospective cohort studiesDiabetes Research and Clinical Practice, 2010
- Metabolic Syndrome and Insulin Resistance Significantly Correlate with Body Mass IndexArchives of Medical Research, 2008